Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBN-101 in Orthopedic Infections
NCT02436876Phase 2Completed
- Sponsor
- Microbion
- Start
- May 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pravibismane in orthopedic infection, osteomyelitis (OM), sponsored by Microbion. Started May 2016; status: completed.
02
Drugs
pravibismane
03
Conditions
orthopedic infectionosteomyelitis (OM)
Beyond the preview
Go deeper on NCT02436876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02436876.